MCMCB Pro
J0899

J0899Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)

HCPCSActiveBETOS O1E

J0899 is a HCPCS Level II code for injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis). It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for J0899

Long descriptor
Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)

The official wording. This is what the code means.

Short descriptor
Argatroban dialysis, auromed

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2023

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0899

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0899 is not quite right, the correct code is very often within a few positions of it.

  • J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
  • J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
  • J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
  • J0894Injection, decitabine, 1 mg
  • J0895Injection, deferoxamine mesylate, 500 mg
  • J0896Injection, luspatercept-aamt, 0.25 mg
  • J0897Injection, denosumab, 1 mg
  • J0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
  • J0900Injection, testosterone enanthate and estradiol valerate, up to 1 ccterminated
  • J0901Vadadustat, oral, 1 mg (for esrd on dialysis)
  • J0911Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
  • J0945Injection, brompheniramine maleate, per 10 mg
  • J1000Injection, depo-estradiol cypionate, up to 5 mg
  • J1010Injection, methylprednisolone acetate, 1 mg
  • J1020Injection, methylprednisolone acetate, 20 mgterminated
  • J1030Injection, methylprednisolone acetate, 40 mgterminated

Questions about J0899

What is HCPCS code J0899?

J0899 is a HCPCS Level II code for injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis). It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0899?

The CMS HCPCS file marks J0899 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is J0899 paid under the physician fee schedule?

J0899 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026